Back to Results

Raia Drogasil SA ADR (RADLY)

Raia Drogasil S.A. ADR is a depositary receipt listed on OTC Markets and tied to Raia Drogasil S.A.’s common shares. The underlying company operates in Brazil’s consumer staples retail space, focusing on the sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its distribution channels include physical stores, telesales, and call centers. Raia Drogasil was founded in 1905 and is headquartered in São Paulo, Brazil.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-RADL.Y
$5.37
40.6% Upside
Undervalued
$5.40
41.4% Upside
Undervalued
Good
December 11, 2026
1.4%
November 3, 2026
25.7x
4.9x
0.8x
6.932 B
8.507 B
19.3%
74.9%
6.1
44.0%
116.0%
Valuation • Fair Value

Raia Drogasil SA ADR (OTC-RADL.Y) Fair Value by Valuation Model

Review the available estimates for Raia Drogasil SA ADR (OTC-RADL.Y), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$5.37

Estimated upside of 40.6% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$5.76

Discounted cash flow valuation reference.

Ben Graham Formula Value

$1.74

Classic Ben Graham valuation formula reference.

DDM Fair Value

$7.59

Dividend discount model valuation reference.

EPV Fair Value

$5.21

Earnings power value estimate.

Comps Fair Value

$4.64

Comparable-company valuation reference.

Analyst Price Target

$5.40

Analysts imply upside of 41.4%.

How to read these valuation models

Use the 8 available valuation references for Raia Drogasil SA ADR (OTC-RADL.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Raia Drogasil SA ADR (OTC-RADL.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

9.001 B

Current operating scale indicator.

Revenue Forecast

8.854 B

Forward revenue estimate.

EBITDA

746.6 M

Current operating profitability reference.

EBITDA Forecast

768.2 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Raia Drogasil SA ADR (OTC-RADL.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Raia Drogasil SA ADR (OTC-RADL.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

-2.74

No elevated caution signal from this screen.

Altman Z-Score

6.1

Relatively strong balance-sheet zone.

FCF / Net Income

116.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Raia Drogasil SA ADR (OTC-RADL.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Raia Drogasil SA ADR (OTC-RADL.Y)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 3, 2026

Days to Earnings

42

Dividend Payment Date

December 11, 2026

Dividend Yield

1.4%

Current income yield reference.

Payout Ratio

44.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Raia Drogasil SA ADR (OTC-RADL.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Raia Drogasil SA ADR (OTC-RADL.Y) Stock Forecast & Technical Outlook

Review Raia Drogasil SA ADR (OTC-RADL.Y) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Raia Drogasil SA ADR (OTC-RADL.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Raia Drogasil SA ADR (OTC-RADL.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Raia Drogasil SA ADR (OTC-RADL.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Raia Drogasil SA ADR (OTC-RADL.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Raia Drogasil SA ADR (OTC-RADL.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Raia Drogasil SA ADR (OTC-RADL.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Raia Drogasil SA ADR (OTC-RADL.Y) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ • Fast Investor Answers

Raia Drogasil SA ADR (OTC-RADL.Y) Stock FAQ

Data-supported answers about Raia Drogasil SA ADR (OTC-RADL.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$5.37
Estimated upside 40.6%
Valuation Rating
Undervalued
Estimated upside of 40.6%
Analyst Target
$5.40
Implied upside 41.4%
Financial Health
Good
Current financial-health read

The current fair value estimate for Raia Drogasil SA ADR (OTC-RADL.Y) is $5.37. This implies an estimated upside of 40.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 40.6% versus the current market price.

The available analyst price target for Raia Drogasil SA ADR (OTC-RADL.Y) is $5.40. The analyst target implies estimated upside of 41.4%.

The current financial health read for Raia Drogasil SA ADR (OTC-RADL.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Raia Drogasil SA ADR (OTC-RADL.Y) is November 3, 2026.

Based on the current data, dividend yield is 1.4%, payment date is December 11, 2026.

The current P/E ratio listed for Raia Drogasil SA ADR (OTC-RADL.Y) is 25.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Raia Drogasil SA ADR is 6.932 B.

The current enterprise value listed for Raia Drogasil SA ADR is 8.507 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Raia Drogasil SA ADR is OTC-RADL.Y, and the stock is listed on OTC Markets.

Raia Drogasil SA ADR (OTC-RADL.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Raia Drogasil SA ADR is 19.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Raia Drogasil SA ADR is 74.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Consumer Staples Distribution & Retail Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

WMT NASDAQ Walmart Inc Fair Value Overvalued Market Cap 873.7 B
COST NASDAQ Costco Wholesale Corp Fair Value Fair Market Cap 398.9 B
TGT NYSE Target Corporation Fair Value Fair Market Cap 72.242 B
SYY NYSE Sysco Corporation Fair Value Fair Market Cap 38.699 B
KR NYSE Kroger Company Fair Value Fair Market Cap 34.585 B
DG NYSE Dollar General Corporation Fair Value Fair Market Cap 27.054 B
CASY NASDAQ Caseys General Stores Inc Fair Value Fair Market Cap 21.615 B
DLTR NASDAQ Dollar Tree Inc Fair Value Fair Market Cap 21.585 B
USFD NYSE US Foods Holding Corp Fair Value Fair Market Cap 20.378 B
PFGC NYSE Performance Food Group Co Fair Value Fair Market Cap 14.523 B
BJ NYSE BJs Wholesale Club Holdings Inc Fair Value Fair Market Cap 11.491 B
SFM NASDAQ Sprouts Farmers Market Inc Fair Value Fair Market Cap 6.404 B
TBBB NYSE BBB Foods Inc Fair Value Fair Market Cap 6.227 B
ACI NYSE Albertsons Companies Fair Value Fair Market Cap 5.858 B
PSMT NASDAQ PriceSmart Inc Fair Value Overvalued Market Cap 5.202 B
CHEF NASDAQ The Chefs Warehouse Inc Fair Value Fair Market Cap 4.421 B
UNFI NYSE United Natural Foods Inc Fair Value Undervalued Market Cap 2.766 B
ANDE NASDAQ The Andersons Inc Fair Value Fair Market Cap 2.253 B
WMK NYSE Weis Markets Inc Fair Value Fair Market Cap 1.799 B
IMKTA NASDAQ Ingles Markets Incorporated Fair Value Fair Market Cap 1.592 B